A. Ernest Toth Jr. is CFO at Aquestive Therapeutics, Inc. (AQST). They have made 1 open-market trade across 1 company since 2026, most recently 2026-05-05.
CIK 0001280273
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AQST | 283,460 | $1.1M |
Shares reported on the most recent Form 4, priced at the 2026-05-07 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AQST | SELL | 2026-03-10 | 2026-03-11 | $4.17 | $243K | -7.5% | -4.0% | -5.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.